CLL Global Research Foundation

 

Upcoming Events
  • Home
  • CLL Information
    • Biology
    • Age & Symptoms
    • Diagnosis
    • Immunology
    • Prognostic Factors
    • Treatments
    • Familial CLL
    • Other
  • News & Views
    • Latest News
    • Upcoming Events
    • President’s Corner
    • Newsletters
    • Multimedia
  • Funded Research
    • Individual Grants
    • Alliance Grants
    • Research Success
    • Other Funding
  • Grant Applications
  • About
    • About Us
    • Mission & Objectives
    • Board of Directors
    • Scientific Advisory Board
  • Donate
  • Contact Us

Grant Applications

Our Research

We have awarded approximately $26 million in research grants. Currently, we are not accepting Letters of Intent. Please continue to check back for future application acceptance announcements.

Research Priorities

The Scientific Advisory Board has outlined the following research priorities. Research proposals should address at least one of the priorities.

  • Proteomics and other post-genomic technologies applied to the investigation of CLL drug development
  • Molecular definition and characterization of prognostic factors, relevant to the natural history of CLL
  • Molecular targets in CLL
  • Identification of and interruption of CLL survival pathways New vaccine and gene therapy approaches
  • New monoclonal antibodies that target CLL cells or restore immune functions
  • Etiology of CLL:
    1. Molecular genetics
    2. Extrinsic factors
  • Methods for quantifying residual disease in CLL Cell/Stroma interaction
APPLICATION AND MORE INFORMATION

Research Application Guidelines
Letter of Intent (word doc)
Full Application (word doc)
Biosketch Form (NH format)
Scientific Advisory Board

CLL: Where We Have Been and Looking to the Future

Renowned CLL experts Dr. Michael Keating and Dr. William Wierda talk with Patient Power Founder Andrew Schorr about the evolution of CLL care and the ways CLL Global Research Foundation is investing in the future.

Watch the interview


CLL GLOBAL RESEARCH FOUNDATION

P.O. Box 301402
Houston, TX 77230

MISSION STATEMENT

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

NEWSLETTER

Join Our Mailing List

Join Us on facebook

f_logo small

Copyright © 2023 CLL Global · Website designed by White Space Web Studio · Log in